Imbruvica
NDC 57962-007, Ibrutinib, suspension, from Pharmacyclics LLC.
- Product NDC
- 57962-007
- Status
- Listed
- Labeler
- Pharmacyclics LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA217003
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/57962-007 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IBRUTINIB70 mg/mL
Pharmacologic classes
Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57962-007-12 | 57962000712 | 1 BOTTLE, GLASS in 1 CARTON (57962-007-12) / 108 mL in 1 BOTTLE, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0dfd0279-ff17-4ea9-89be-9803c71bab44
Use it
Look up 57962-007 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57962-007 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57962-007. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.